Chicago

cures-within-reach-rare-diseases

While Cures Within Reach is disease-agnostic and geography-agnostic, some of our funding partners have strategic interests in specific geographic regions.  Therefore, in addition to our disease-specific repurposing communities, we work to increase the repurposing research focused on improving the quality and length of life within the Chicagoland region through the speed and cost-effectiveness of medical repurposing.

 

Our events and research within the Chicagoland Repurposing Community all focus on connecting our many stakeholder groups together in our shared goal: driving more treatments to more patients more quickly through repurposing.

 

Open Funding Opportunities for the Chicago Area:

  • US Based Repurposing Clinical Trials to Address Health Equity 2024: INVITE ONLY accepting budgets of up to $75,000 for repurposing clinical trials to address health equity, including repurposing clinical trials that EITHER are 1) led by an underrepresented researcher OR 2) address health disparities among underrepresented patients OR 3) both 1) and 2). PROPOSAL DEADLINE CLOSED; SUBMISSIONS UNDER REVIEW
  • Impacting Blood Cancers through Clinical Repurposing Trials: clinical trials in Chicago are eligible! Accepting budgets of up to $75,000 from institutions worldwide for clinical repurposing trials targeting any blood cancer, with a preference for trials impacting multiple myeloma and/or myelodysplastic syndromes. LOI DEADLINE CLOSED; SUBMISSIONS UNDER REVIEW
  • Repurposing Research for Chicago 2024: accepting budgets of up to $100,000 for clinical repurposing trials from Chicago area research institutions in one or more of the following tracks. LOI DEADLINE CLOSED; SUBMISSIONS UNDER REVIEW

More information on our Funding Opportunities / RFPs page.

Current Chicago Trials

No results found.

Events

Diversity of Clinical Trial Researchers and Patients: A Repurposing Opportunity?
November 2021
Virtual
A dialogue on the dual opportunities of clinical trial diversity to impact health disparities and/or improve minority leadership in scientific research.

Real World Data Through a Patient’s Lens
October 2021
Virtual
A conversation on Real World Data (RWD) and case reports from clinicians and researchers.

Repurposing for Pediatric Patients: Best Practices and Lessons Learned
November 2020
Virtual
A patient-focused conversation on the opportunities that repurposing drugs, devices and other treatments provide for the pediatric patient population.

How Patients Impact the 505(b)(2) Regulatory Process
October 2020
Virtual
A patient-focused conversation on the 505(b)(2) regulatory process and how patients, caregivers and patient advocacy groups can engage with both industry and regulators to support the drug development process, share their real-world perspectives for clinical trial planning and represent the patient view throughout the drug approval process.

CureAccelerator Live for Chicago 2020
September 2020
Virtual
Four finalists from the greater Chicago area competing for up to $50,000 to fund their repurposing clinical trials.

CureAccelerator Live! for Rare Diseases 2020
June 2020
Virtual
Five finalists from the US competing for up to $50,000 to fund their repurposing clinical trials impacting rare disease patients.

Cutting Edge Treatments and Technologies for Diabetes Patients
October 2019
Chicago, IL
A patient education event on groundbreaking treatments, technologies and strategies for diabetes patients to manage their disease, reduce co-morbidities and improve quality of life.

2018 Global Health Repurposing Awards
June 2018
Chicago, IL
Recognizing leaders from industry, research and philanthropic who have created patient impact through the repurposing in oncology.

2017 Global Health Repurposing Awards
June 2017
Chicago, IL
Recognizing leaders from industry, research and philanthropic who have created patient impact through repurposing in rare diseases.

CureAccelerator Live! for Oncology 2017
November 2017
Chicago, IL
Five finalists from institutions across the US competing for up to $50,000 to fund their oncology repurposing clinical trials.

CureAccelerator Live! for Chicago 2016
March 2016
Chicago, IL
Three finalists from Chicago-area institutions competing for up to $50,000 to fund their groundbreaking repurposing clinical trials.